Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT01606735
Brief Summary:
This study will test the efficacy and safety of IBI-10090 in the treatment of ocular inflammation after ocular surgery.
Study:
NCT01606735
Study Brief:
Protocol Section:
NCT01606735